Tuesday, 17 November, 2026
Biotech Boost: Moderna Backer Bets £100M on AI-Driven Drug Startups in London
By TechShots Studio

Venture firm Flagship Pioneering is investing £100 million to launch its first company-creation lab outside the U.S. in London. Aiming to recruit 50 scientist-entrepreneurs and attract £500 million more from partners, the Flagship Origination Lab will leverage Britain’s National Health Service patient data to build AI-native drug developers—marking a major vote of confidence in the U.K.’s life sciences sector.
Read full story at REUTERS